[Anti-infective drug therapy in ophthalmology--Part 2: viral infections]

T Reinhard1, L L Hansen, M Pache

  • 1Augenklinik des Universitätsklinikums, Freiburg. Reinhard@aug.ukl.uni-freiburg.de

Klinische Monatsblatter Fur Augenheilkunde
|February 19, 2005
PubMed

Insights

This review covers viral ophthalmological diseases, including those caused by herpes simplex virus and adenovirus. It highlights therapeutic options, focusing on evidence from randomized trials for effective treatment strategies.

Area of Science:

  • Ophthalmology
  • Virology
  • Infectious Diseases

Context:

  • Viral infections pose significant threats to ocular health.
  • Several viruses, including herpes simplex virus (HSV), varicella zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), and adenovirus, are implicated in causing various eye diseases.

Purpose:

  • To provide a concise overview of ophthalmological diseases caused by common human viruses.
  • To discuss the primary therapeutic strategies for these viral eye conditions.
  • To emphasize the importance of evidence-based treatments derived from prospective randomized trials.

Summary:

  • The review briefly describes key ophthalmological conditions resulting from HSV, VZV, EBV, CMV, and adenovirus infections.
  • It examines the main treatment options available for these viral ocular diseases.
  • A particular focus is placed on the findings from prospective randomized controlled trials to guide therapeutic decisions.

Impact:

  • Enhances understanding of viral etiologies in ophthalmology.
  • Informs clinical practice by highlighting evidence-based therapeutic approaches.
  • Aids in the management of sight-threatening viral eye infections.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...